Skip to main navigation Skip to search Skip to main content

Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Results of a Long-Term, Phase 3, Open-Label Extension Trial

  • Robert L. Findling
  • , Alain Katic
  • , Michael Liebowitz
  • , James Waxmonsky
  • , Nicholas Fry
  • , Peibing Qin
  • , Ilmiya Yarullina
  • , Zulane Maldonado-Cruz
  • , V. Rose Lieberman
  • , Jonathan Rubin

Research output: Contribution to journal › Article › peer-review

2   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Results of a Long-Term, Phase 3, Open-Label Extension Trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science